Literature DB >> 16174282

Predictors of diabetic end-stage renal disease in Japan.

Kunitoshi Iseki1.   

Abstract

Diabetes mellitus (DM) has been the leading cause of incident dialysis in Japan since 1998, according to the Japanese Society for Dialysis Therapy (JSDT). In particular, the number of male DM dialysis patients is increasing. DM is becoming a worldwide epidemic in both developed and developing countries. Strategies to detect individuals at high-risk of developing CKD and end-stage renal disease (ESRD) are needed that can be implemented on a population-basis. Among the commonly measured variables, dipstick urinalysis (proteinuria, haematuria), blood pressure, serum creatinine, body mass index (BMI), and serum uric acid are significant predictors of ESRD. Recently, we evaluated the effect of DM as a risk factor of developing ESRD. DM was diagnosed when the fasting plasma glucose (FPG) was 126 mg/dL or more in participants (n = 78529) of the 1993 screening program in Okinawa. The prevalence of DM was 5.2%. The odds ratio (95% CI) of DM for developing ESRD was 3.098 (1.738-5.525, P = 0.0001) after adjusting for possible confounding variables. Early detection and treatment of DM might prevent DM-related ESRD. We examined 7125 non-DM screenees who underwent a 1-day health check between April 1997 and March 1998. They were followed-up until March 2000 to determine whether they developed DM. Over the 2 years, the cumulative incidence of DM was 2.3%, 2.9% in men and 1.3% in women. Proteinuria was the most robust predictor of the development of DM; the adjusted relative risk (95% CI) was 1.90 (1.14-3.17). Obesity, per se, is also recognized as a risk factor for developing proteinuria. The higher the BMI, the higher the risk of developing ESRD; the adjusted odds ratio (95% CI) was 1.273 (1.121-1.446, P = 0.0002) for men. Other than being overweight (BMI = 25.0 kg/m2), a smoking habit was a significant predictor of developing proteinuria. The prevalence of obesity and DM is increasing in Japan. It is possible that the impact of obesity and complications of DM are different among races and ethnicities. Public relations regarding the risk of DM and its complications are especially important in Asian countries. Asians have more fat than non-Asians, even at the same BMI levels. Knowledge of the predictors of DM-ESRD is crucial as a first step toward prevention. Consistent with this notion, initiatives on the management of CKD and ESRD were recently organized in Japan and internationally.

Entities:  

Mesh:

Year:  2005        PMID: 16174282     DOI: 10.1111/j.1440-1797.2005.00447.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  8 in total

1.  Outcomes of emergency surgery for acute abdomen in dialysis patients: experience of a single community hospital.

Authors:  Takahiro Tomino; Hideaki Uchiyama; Shinji Itoh; Takahiro Higashi; Ai Edagawa; Akinori Egashira; Daihiko Eguchi; Hirofumi Kawanaka; Toshiroh Okuyama; Masahiro Tateishi; Daisuke Korenaga; Kenji Takenaka
Journal:  Surg Today       Date:  2013-07-25       Impact factor: 2.549

2.  Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial.

Authors:  Sawako Kato; Shoichi Maruyama; Hirofumi Makino; Jun Wada; Daisuke Ogawa; Takashi Uzu; Hisazumi Araki; Daisuke Koya; Keizo Kanasaki; Yutaka Oiso; Motomitsu Goto; Akira Nishiyama; Hiroyuki Kobori; Enyu Imai; Masahiko Ando; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2015-03-21       Impact factor: 2.801

Review 3.  Diabetes and its comorbidities--where East meets West.

Authors:  Alice P S Kong; Gang Xu; Nicola Brown; Wing-Yee So; Ronald C W Ma; Juliana C N Chan
Journal:  Nat Rev Endocrinol       Date:  2013-05-28       Impact factor: 43.330

4.  Efficacy of a disease management program focused on acquisition of self-management skills in pre-dialysis patients with diabetic nephropathy: 24 months follow-up.

Authors:  Kana Kazawa; Yae Takeshita; Noriaki Yorioka; Michiko Moriyama
Journal:  J Nephrol       Date:  2014-09-24       Impact factor: 3.902

5.  Cerebrovascular CO2 reactivity during isoflurane-nitrous oxide anesthesia in patients with chronic renal failure.

Authors:  Kazuyoshi Ishida; Masato Uchida; Kohji Utada; Atsuo Yamashita; Satoshi Yamashita; Shiro Fukuda; Mishiya Matsumoto; Takefumi Sakabe
Journal:  J Anesth       Date:  2017-11-04       Impact factor: 2.078

6.  The relationship between the regional abdominal adipose tissue distribution and the serum uric acid levels in people with type 2 diabetes mellitus.

Authors:  Tae Ho Kim; Seong Su Lee; Ji Han Yoo; Sung Rae Kim; Soon Jib Yoo; Ho Cheol Song; Yong-Soo Kim; Euy Jin Choi; Yong Kyun Kim
Journal:  Diabetol Metab Syndr       Date:  2012-02-03       Impact factor: 3.320

7.  Randomized control trial for the assessment of the anti-albuminuric effects of topiroxostat in hyperuricemic patients with diabetic nephropathy (the ETUDE study).

Authors:  Sawako Kato; Masahiko Ando; Toshihiro Mizukoshi; Takanobu Nagata; Takayuki Katsuno; Tomoki Kosugi; Naotake Tsuboi; Shoichi Maruyama
Journal:  Nagoya J Med Sci       Date:  2016-05       Impact factor: 1.131

8.  [Epidemiological profile of terminal chronic renal failure in the region of Sfax].

Authors:  Yosr Chaabouni; Sourour Yaich; Azza Khedhiri; Mohamed Ali Zayen; Mahmoud Kharrat; Khawla Kammoun; Faical Jarraya; Mohamed Ben Hmida; Jamal Damak; Jamil Hachicha
Journal:  Pan Afr Med J       Date:  2018-01-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.